A-205804 (A205804; A 205804) is a novel selective inhibitor of E-selectin and intercellular adhesion molecule-1 (ICAM-1) expression (IC50 = 20 nM and 25 nM) with potential anticancer activity. ICAM1 is a protein associated with diseases such as Malaria and Hepatocellular Carcinoma. In human vascular endothelial cells using whole-cell high-throughput assay, it was shown that A-205804 exhibited potent and selective inhibition to E-selectin and ICAM-1 with low concentrations.
Physicochemical Properties
| Molecular Formula | C15H12N2OS2 | |
| Molecular Weight | 300.4 | |
| Exact Mass | 300.039 | |
| CAS # | 251992-66-2 | |
| Related CAS # |
|
|
| PubChem CID | 9839311 | |
| Appearance | Off-white to light yellow solid powder | |
| Density | 1.4±0.1 g/cm3 | |
| Boiling Point | 581.3±45.0 °C at 760 mmHg | |
| Melting Point | 198-199℃ | |
| Flash Point | 305.4±28.7 °C | |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C | |
| Index of Refraction | 1.738 | |
| LogP | 3.07 | |
| Hydrogen Bond Donor Count | 1 | |
| Hydrogen Bond Acceptor Count | 4 | |
| Rotatable Bond Count | 3 | |
| Heavy Atom Count | 20 | |
| Complexity | 358 | |
| Defined Atom Stereocenter Count | 0 | |
| InChi Key | QQGWEXFLMJGCAL-UHFFFAOYSA-N | |
| InChi Code | 1S/C15H12N2OS2/c1-9-2-4-10(5-3-9)19-13-7-17-8-14-11(13)6-12(20-14)15(16)18/h2-8H,1H3,(H2,16,18) | |
| Chemical Name | 4-[(4-Methylphenyl)thio]thieno[2,3-c]pyridine-2-carboxamide | |
| Synonyms |
|
|
| HS Tariff Code | 2934.99.9001 | |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | At an IC50 of 152 μM, A-205804 displays cellular toxicity for HUVEC[1]. In an in vitro flow experiment, A-205804 effectively inhibits cell-cell adhesion, indicating its applicability in a model physiological system[1]. |
| ln Vivo | For rats, A-205804 (5 mg/kg; po) exhibits a half-life of one hour[1]. For two weeks, A-205804 (10 mg/kg; po; three times per week) reduces the expression of E-selectin on the endothelium vascular niche cells in mice[2]. |
| Animal Protocol |
Animal/Disease Models: C57BL/6 mice[2] Doses: 10 mg/kg Route of Administration: Oral administration, 3 times per week, for 2 weeks Experimental Results: Efficiently diminished the expression of E -selectin on the endothelial vascular niche cells Animal/Disease Models: Rat[1] Doses: 5 mg/kg (pharmacokinetic/PK Analysis) Route of Administration: Oral administration Experimental Results: t1/2 = 1 hour |
| References |
[1]. Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells. 1. Selective inhibition of ICAM-1 and E-selectin expression. J Med Chem. 2001 Mar 15;44(6):988-1002. [2]. RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice. Blood Adv. 2018 Mar 13;2(5):509-515. |
| Additional Infomation | 4-[(4-methylphenyl)thio]-2-thieno[2,3-c]pyridinecarboxamide is an aryl sulfide. |
Solubility Data
| Solubility (In Vitro) |
|
|||
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (6.92 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (6.92 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.3289 mL | 16.6445 mL | 33.2889 mL | |
| 5 mM | 0.6658 mL | 3.3289 mL | 6.6578 mL | |
| 10 mM | 0.3329 mL | 1.6644 mL | 3.3289 mL |